This is a controversial mechanism of increased levels of cardiospecific Tns in the bloodstream. In the literature, there are works confirming the expression of cardiospecific Tns in skeletal muscle tissue in patients with CKD and hereditary skeletal myopathies, as well as studies that refute this hypothesis. Here, TNS1 is linked to skeletal muscle disorder.